Clinical Pharmacology of MDA [3,4-methylenedioxyamphetamine]

Completed · Not applicable · Has a placebo group

Conditions studied: Healthy

In brief

The purpose of this study is to investigate the pharmacological and cognitive effects of MDA in healthy humans.

Key facts

Study ID

NCT00823407

Run by

California Pacific Medical Center Research Institute

People needed

12

Starts

2009-01-01

Expected to finish

2009-07-01

Last updated by the study team

2013-05-31

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy males and females age 18-50
• Fluent English speaker
• Willing and able to give written consent

You may not qualify if…

• Body mass index > 30 or < 18
• Pregnancy or lactation
• FOR MORE DETAILS CONTACT THE RESEARCH CLINIC.

Where it is running

• CPMC Addiction & Pharmacology Research Laboratory (APRL) — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.